UROTHELIAL CANCER
Clinical trials for UROTHELIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CANCER trials appear
Sign up with your email to follow new studies for UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug combo shows promise against tough bladder cancer
Disease control TerminatedThis study tested an experimental drug called enfortumab vedotin, alone or with other cancer treatments, in people with advanced or muscle-invasive bladder cancer. The goal was to see how safe the combinations were and whether they could shrink tumors. The study included 348 part…
Matched conditions: UROTHELIAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 26, 2026 11:32 UTC
-
Experimental cancer combo trial halted early
Disease control TerminatedThis early-stage study tested a new drug, PF-07265028, alone or with another drug (sasanlimab) in people with advanced solid tumors like lung, stomach, and head & neck cancers. The goal was to find the safest dose and see if the drugs shrink tumors. The study was terminated early…
Matched conditions: UROTHELIAL CANCER
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 22, 2026 14:02 UTC